Find clinical trials for Ovarian Cancer in Barcelona, CT
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Ovarian Cancer trials near Barcelona, CT, ESP:
in participants with human epidermal growth factor 2 (HER2)-expressing (immunohistochemistry \[IHC\] 3+/2+/1+) advanced high-grade epithelial ovarian...
Phase 3
Barcelona, Spain and 109 other locations
of olaparib maintenance monotherapy in relapsed high grade serous ovarian cancer (HGSOC) patients (including patients with primary ...
Phase 3
Barcelona, Spain and 126 other locations
the safety and efficacy of avutometinib (VS-6766) monotherapy and in combination with defactinib in subjects with recurrent Low-Grade Serous Ovarian...
Phase 2
Barcelona, Spain and 46 other locations
positive, recurrent platinum sensitive, high-grade epithelial ovarian, primary peritoneal, or fallopian tube cancer following 1 pri...
Phase 2
Barcelona, Spain and 70 other locations
therapy for the treatment of participants with advanced/recurrent ovarian cancer.Substudy 1 will investigate the safety, tolerabili...
Phase 1, Phase 2
Barcelona, Spain and 19 other locations
of alpelisib and olaparib compared with single agent cytotoxic chemotherapy in patients with platinum resistant or refractory high-grade serous ovarian...
Phase 3
Barcelona, Catalonia, Spain and 92 other locations
Olaparib Monotherapy in Patients with BRCA Mutated Ovarian Cancer following First Line Platinum Based Chemotherapy....
Phase 3
Barcelona, Spain and 176 other locations
To evaluate the efficacy of romiplostim for the treatment of CIT in patients receiving chemotherapy for the treatment of NSCLC, ovarian cancer...
Phase 3
Barcelona, Catalonia, Spain and 139 other locations
Researchers are looking for other ways to treat relapsed high-grade serous ovarian cancer. Relapsed means the cancer came ...
Phase 1, Phase 2
Barcelona, Spain and 15 other locations
This study will assess the safety and efficacy of avutometinib (VS-6766) in combination with defactinib versus Investigator's choice of treatments (I...
Phase 3
Barcelona, Spain and 104 other locations
Clinical trials
Research sites
Resources
Legal